
“The market is projected to grow from $222.9 billion in 2025 to $362.3 billion by 2031 at an 8.7% CAGR, fueled by rising skin-disease prevalence and advances in microneedles, nanocarriers, smart patches, 3D-printed formulations and AI-assisted drug discovery.” Boston, Aug. 27, 2026 (GLOBE NEWSWIRE) -- The global topical drug delivery market is projected to grow from $222.9 billion in 2025 to $362.3 billion by 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031, according to t
The U.S. Organic Beverages Market was valued at approximately USD 10.31 billion in 2025 and is projected to reach approximately USD 33.42 billion by 2035, at CAGR of 12.52% from 2026 to 2035. Similarly, The Europe Organic Beverages Market is estimated to be USD 7.30 Billion in 2025 and is projected to reach USD 24.91 Billion by 2035, growing at a CAGR of approximately 19.63% during 2026–2035. Austin, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Organic Beverages Market Size & Growth Insights: According to
newsU.S. Market to Reach USD 594.3 Million and Europe USD 526.6 Million by 2035 as HDR Procedures and Image-Guided Treatment Expand Austin, Texas, Aug. 27, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Brachytherapy Market was valued at USD 1,092.0 Million in 2025 and is projected to reach USD 2,194.0 Million by 2035 , growing at a CAGR of 7.23% from 2026 to 2035 . Market growth is supported by the increasing global cancer burden, wider use of minimally invasive radiation therapy, and conti

The blood-based biomarkers market is witnessing robust growth due to the increasing demand for non-invasive diagnostic solutions and the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions. Advances in genomics, proteomics, and liquid biopsy technologies have significantly improved the accuracy and clinical utility of blood-based biomarkers. Growing adoption of precision medicine, expanding biomarker-based drug development, and increasing i
“Rising chronic disease, clinician shortages and healthcare digitalization are driving AI adoption across diagnostics, patient monitoring and drug discovery, while the deep learning segment is projected to grow at approximately 36.1% as hospitals scale image analysis and clinical decision-support platforms.” Boston, Aug. 27, 2026 (GLOBE NEWSWIRE) -- The global cognitive computing and artificial intelligence systems market in healthcare is undergoing rapid structural expansion, powered by acceler
news“The market is projected to grow from $222.9 billion in 2025 to $362.3 billion by 2031 at an 8.7% CAGR, fueled by rising skin-disease prevalence and advances in microneedles, nanocarriers, smart patches, 3D-printed formulations and AI-assisted drug discovery.” Boston, Aug. 27, 2026 (GLOBE NEWSWIRE) -- The global topical drug delivery market is projected to grow from $222.9 billion in 2025 to $362.3 billion by 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031, according to t

CALGARY, Alberta, Aug. 27, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Inventronics Limited (TSX Venture: IVX), please note that certain language was inadvertently carried forward from the Company's Q1 2026 press release. The corrected release follows: Inventronics Limited (“Corporation”) (IVX: TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada and the U
RESTON, Va., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Laser Light Holdings, Ltd. ("Laser Light") today announced that it has entered into a definitive agreement under which Keystone Optical Network, LLC has committed to invest up to $75 million in Laser Light. “Keystone Optical Networking Company’s commitment to Laser Light Holdings represents far more than an investment in our company. It is a strong vote of confidence in what we are building, the strategy we are executing, and the opportunity we see
newsWINNIPEG, Manitoba, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its second quarter 2026 financial results. Second Quarter 2026 Financial Highlights: Total revenue for the three months ended June 30, 2026 was $8,143 compared to $27,997 for the three months ended June 30, 2025. Revenue in the second quarter of 2026 reflected the Company’s continued early-stage commercialization of its revyve ® product line, including ini

CreatorsJet expands its core media kit platform with a simpler way for creators to discover and pursue relevant brand partnerships through its new AI-powered sponsorship discovery feature. Middletown, DELAWARE, Aug. 27, 2026 (GLOBE NEWSWIRE) -- CreatorsJet , the leading media kit platform for content creators, today announced the launch of its AI-powered sponsorship discovery feature. It helps creators identify brands actively sponsoring content and research potential partnership opportunities d
Q2 2026 key highlights NNIT's financial performance was in line with initial expectations, despite continued customer caution, particularly within the life science segments. However, order entry improved during the quarter across all regions, supported by targeted growth initiatives aimed at strengthening sales execution. Reported group revenue declined 4.5% to DKK 441.6m, corresponding to constant currency revenue growth of -4.4%. The decline was primarily driven by the life science regions, wh
news“Machine learning is helping food companies reformulate products, strengthen allergen control and personalize nutrition while some manufacturers report four- to five-fold faster R&D and expand investment in AI-enabled production, quality inspection and supply-chain intelligence.” Boston, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence is fundamentally redefining how the global gluten-free food industry operates — accelerating R&D timelines, hardening supply chains against commodity vol

CALGARY, Alberta, Aug. 27, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Inventronics Limited (TSX Venture: IVX), please note that certain language was inadvertently carried forward from the Company's Q1 2026 press release. The corrected release follows: Inventronics Limited (“Corporation”) (IVX: TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada and the U
SYDNEY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Omni Bridgeway Limited (ASX: OBL), the leading global alternative asset manager dedicated to legal assets, today released its results for the 12 months ended 30 June 2026 (FY26), reporting record cash investment proceeds and record new commitments, and achieving or exceeding each of the targets set for the year. Highlights A milestone year: FY26 marks 40 years since the founding of the business and 25 years since listing on the ASX, underscoring Omni Bri
newsSHANGHAI, Aug. 27, 2026 (GLOBE NEWSWIRE) -- FinVolution Group (“FinVolution” or the “Company”) (NYSE: FINV), a leading fintech platform across China and overseas markets, today announced its unaudited financial results for the second quarter ended June 30, 2026. For the Three Months Ended/As of YoY Change June 30, 2025 June 30, 2026 Total Transaction Volume (RMB in billions) 1 54.0 44.8 -17.0% - Chinese Mainland 2 50.8 41.0 -19.3% - Overseas Markets 3 3.2 3.8 18.8% Total Outstanding Loan Balance